ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2022
Establishing irremediable psychiatric suffering in the context of medical assistance in dying in the Netherlands: a qualitative study.
Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Review
- Addressing 'futility' in psychiatry: a consensus statement.Psychological medicine · 2026Article
- Understanding death wishes in later life: a narrative review.Frontiers in psychiatry · 2026Review
- Mapping ethical issues encompassing end-of-life care for persons experiencing severe and persistent mental illness: a qualitative study.BMC medical ethics · 2025Article
- Clinical practice guidelines for the treatment of borderline personality disorder: a systematic review of best practice in anticipation of MAiD MD-SUMC.Borderline personality disorder and emotion dysregulation · 2025Article
- Assessing and managing patients with borderline personality disorder requesting medical assistance in dying.Frontiers in psychiatry · 2024Article
- Veterinary ethics and companion animal euthanasia: what can we learn from critical disability studies?Frontiers in veterinary science · 2024Review
- Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion.Healthcare policy = Politiques de sante · 2023Article
- Mapping the ethical aspects in end-of-life care for persons with a severe and persistent mental illness: A scoping review of the literature.Frontiers in psychiatry · 2023Article
- Irremediable Psychiatric Suffering in The Context of Medical Assistance in Dying: A Delphi-Study.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2022Article
- Responding to Bill C-7.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022Article
- Physician Assisted Death for Psychiatric Suffering: Experiences in the Netherlands.Frontiers in psychiatry · 2022Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEstablishing irremediability of suffering is a central challenge in determining the appropriateness of medical assistance in dying (MAiD) for patients with a psychiatric disorder. We sought to evaluate how experienced psychiatrists define irremediable psychiatric suffering in the context of MAiD and what challenges they face while establishing irremediable psychiatric suffering.
methodsWe conducted a qualitative study of psychiatrists in the Netherlands with experience assessing irremediable psychiatric suffering in the context of MAiD. We collected data from in-depth, semistructured interviews focused on the definition of irremediable psychiatric suffering and on the challenges in establishing irremediability. We analyzed themes using a modified grounded theory approach.
resultsThe study included 11 psychiatrists. Although irremediable psychiatric suffering is a prospective concept, most participants relied on retrospective dimensions to define it, such as a history of failed treatments, and expressed that uncertainty was inevitable in this process. When establishing irremediable psychiatric suffering, participants identified challenges related to diagnosis and treatment. The main diagnostic challenge identified was the frequent co-occurrence of more than 1 psychiatric diagnosis. Important challenges related to treatment included assessing the quality of past treatments, establishing when limits of treatment had been reached and managing "treatment fatigue."
interpretationChallenges regarding the definition, diagnosis and treatment of irremediable psychiatric suffering complicate the process of establishing it in the context of MAiD. Development of consensus clinical criteria for irremediable psychiatric suffering in this context and further research to understand "treatment fatigue" among patients with psychiatric disorders may help address these challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.